Journal Article

Role of Patient-Derived Models of Cancer in Translational Oncology

Idrisova, K. F., Simon, H.-U., Gomzikova, M. O.

2022

Overview

Cancer is a heterogeneous disease. Each individual tumor is unique and characterized by structural, cellular, genetic and molecular features. Therefore, patient-derived cancer models are indispensable tools in cancer research and have been actively introduced into the healthcare system. For instance, patient-derived models provide a good reproducibility of susceptibility and resistance of cancer cells against drugs, allowing personalized therapy for patients. In this article, we review the advantages and disadvantages of the following patient-derived models of cancer: (1) PDC—patient-derived cell culture, (2) PDS—patient-derived spheroids and PDO—patient-derived organoids, (3) PDTSC—patient-derived tissue slice cultures, (4) PDX—patient-derived xenografts, humanized PDX, as well as PDXC—PDX-derived cell cultures and PDXO—PDX-derived organoids. We also provide an overview of current clinical investigations and new developments in the area of patient-derived cancer models. Moreover, attention is paid to databases of patient-derived cancer models, which are collected in specialized repositories. We believe that the widespread use of patient-derived cancer models will improve our knowledge in cancer cell biology and contribute to the development of more effective personalized cancer treatment strategies.

• Publisher: MDPI AG,MDPI
• Subject: Ascites / Biobanks / Cancer / Cell culture / Clinical trials / Data collection / Gene expression / Medical research / Methods / Mutation / Oncology, Experimental / Organoids / Patients / Review / Spheroids / Success / Translational research / Tumor cell lines / Tumors / Xenografts